« Return to News | CROs/Service Providers

MDS Pharma's First Quarter Revenues Down 12%

Friday, March 13, 2009 08:00 AM

Revenues for contract research organization (CRO) MDS Pharma Services continue to fall as a result of client delays in late-stage research and decreased activity in preclinical and bioanalytical services.

First quarter net revenues for the CRO, a subsidiary of MDS, were down 12% from Q1 last year to $106 million. New business wins for Pharma Services also were down significantly over last year. New business wins for the first quarter 2009 were $104 million, down 41% from $177 million in the same period of 2008. MDS attributed this decline to “soft late-stage orders as customers continue to delay awards while reprioritizing their research and development projects.”

The CRO reported adjusted EBITDA of $8 million, up from $6 million last year, as a result of productivity gains from restructuring actions initiated in 2008.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.